Viewing Study NCT06814067

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2026-05-30 @ 3:00 PM
Study NCT ID: NCT06814067
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-02-07
First Post: 2025-02-03
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Phase II Multi-centered Study of Perioperative Ivonescimab Versus Pembrolizumab Combined with Standard of Care (SOC) in Patients with Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma
Sponsor: Fudan University
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Head and Neck Squamous Cell Carcinoma View
None Head and Neck Squamous Cell Carcinoma HNSCC View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant therapy View
None Immunotherapy View
None Ivonescimab View
None pembrolizumab View